NAMPT and obesity disorder: Prolonged visfatin treatment leading to a diabetic phenotype in Mus musculus [155] while another study reported that serum visfatin is linked to T2DM regardless of insulin resistance and obesity [156], indicating that the dual impact of visfatin on diabetes may be influenced by its concentration and requires further comprehensive clinical investigations.